Ricerca
Prescrizione di antibiotici in Pediatria tra il 2012 e il 2018 in Regione Piemonte
Prescription of antibiotics in PAediatrics in the Piedmont Region (ITALY) between 2012-2018
Aldo Ravaglia1, Andrea Guala2, Roberto Gnavi3, Alberto Borraccino4; GdL Antibiotici Piemonte
1Pediatra di famiglia, Chivasso (Torino)
2SC di Pediatria, Dipartimento Materno-Infantile, Ospedale Castelli, ASL Verbano Cusio Ossola, Verbania
3Servizio di Epidemiologia, ASL TO3, Grugliasco (Torino)
4Dipartimento di Scienze della Sanità Pubblica e Pediatriche, Università di Torino
Gruppo di Lavoro Antibiotici Piemonte: Alberto Borraccino, Aldo Ravaglia, Andrea Guala, Elga Cagliero, Giulia Costagliola,
Giulia Pruccoli, Giuliana Dossi, Loredano Giorni, Raffaella Baroetto, Roberto Gnavi
Novembre 2020 - pagg. 575 -580 | DOI: 10.53126/MEB39575
Abstract
Background - he variability in the prescription of antibiotics in the infant population registers changes that cannot always be explained by the associated morbidity alone. Italy, despite its decreasing trend, is still among those countries with the highest prescriptions and shows an important inter-regional variability. The Pharmaceutical Service of the Piedmont Region gave the start to a working group with the task of describing the prescriptive activities, evaluating any internal variability and proposing strategies for improvement.
Aim - The aim of the work is to describe the results achieved in Piedmont in 2012-2018 with regard to the paediatric treatment.
Materials and methods - Data on prescriptions in paediatrics, grouped for ATC, were obtained from the regional pharmaceutical prescription system. Prescriptive rates and treatment prevalence - children with at least one prescription during the year - were calculated for the total number of residents.
Results - The overall rate was reduced from 931 to 689 prescriptions per thousand children. In the same period, the prevalence of prescriptions was also reduced from 45.5% to 34.8%. Non-associated amoxicillin accounted for less than 15% of prescriptions, while clavulanate amoxicillin was the most widely used antibiotic with the 45% of the prescriptions. The ratio of amoxicillin to clavulanate amoxicillin remained strongly negative over the entire period, although it slightly improved from 0.27 to 0.42.
Conclusion - The proportion of treatments, though decreasing, is still far from those of other virtuous European nations. Amoxicillin, unlike what suggested by inter-national and national guidelines, is the least prescribed antibiotics with an excess in clavulanate amoxicillin prescriptions that is difficult to explain. According to recent AIFA reports, the observed differences seem to depend partly on the patient's family but mainly on the prescriptive behaviours. Therefore, the professionals involved should compare prescribing practices to further improve prescriptive appropriateness.
Aim - The aim of the work is to describe the results achieved in Piedmont in 2012-2018 with regard to the paediatric treatment.
Materials and methods - Data on prescriptions in paediatrics, grouped for ATC, were obtained from the regional pharmaceutical prescription system. Prescriptive rates and treatment prevalence - children with at least one prescription during the year - were calculated for the total number of residents.
Results - The overall rate was reduced from 931 to 689 prescriptions per thousand children. In the same period, the prevalence of prescriptions was also reduced from 45.5% to 34.8%. Non-associated amoxicillin accounted for less than 15% of prescriptions, while clavulanate amoxicillin was the most widely used antibiotic with the 45% of the prescriptions. The ratio of amoxicillin to clavulanate amoxicillin remained strongly negative over the entire period, although it slightly improved from 0.27 to 0.42.
Conclusion - The proportion of treatments, though decreasing, is still far from those of other virtuous European nations. Amoxicillin, unlike what suggested by inter-national and national guidelines, is the least prescribed antibiotics with an excess in clavulanate amoxicillin prescriptions that is difficult to explain. According to recent AIFA reports, the observed differences seem to depend partly on the patient's family but mainly on the prescriptive behaviours. Therefore, the professionals involved should compare prescribing practices to further improve prescriptive appropriateness.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Choy CY, Hsu LY. World Antibiotic Awareness Week. Ann Acad Med Singapore 2017; 46(11):413-4.
2. European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union. 2015.
3. Le Galès C. Évolution, déterminants et régulation des dépenses de médicaments en France. Médecine/Sciences 2018;34:83-6.
4. Franc C. Le partage de la couverture maladie entre assurances obligatoire et complémentaires - Les défauts d’un système mixte. Médecine/Sciences 2017;33:1097-104.
5. Osservatorio Nazionale sull’impiego dei Medicinali. L’uso degli antibiotici in Italia. Rapporto Nazionale 2018. Roma: AIFA, 2019.
6. Moro M, Resi D, Morri M, et al. Prescrizione di antibiotici in età pediatrica nella Regione Emilia-Romagna. Medico e Bambino 2002;21 (4):259-60.
7. Di Mario S, Gagliotti C, Buttazzi R, et al.; Progetto ProBA 2014. Uso di antibiotici in Pediatria. Medico e Bambino 2017;36(9):578-83.
8. ISTAT. http://demo.istat.it (ultimo accesso il 5 luglio 2019).
9. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child 2011;96(6):590-5.
10. European Community. Prudent use of antimicrobial agents in human medicine: 3rd report on implementation of the Council recommendation. 2016.
11. Piovani D, Clavenna A, Cartabia M, et al. Assessing the quality of paediatric antibiotic prescribing by community paediatricians: a database analysis of prescribing in Lombardy. BMJ Paediatr Open 2017;1(1): e000169.
12. de Bie S, Kaguelidou F, Verhamme KM, et al.; ARPEC study. Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing. Pediatr Infect Dis J 2016;35 (12):1317-23.
13. Contiguglia N, Marchetti F (lettera). Il conflitto di interessi ‘di cortesia’. Medico e Bambino 2019;38(7):422-4.
14. Garattini S (prefazione). In: Bobbio M. Giuro di esercitare la medicina in libertà e indipendenza. Medici e industria. Einaudi, 2004, 289 pagg.
15. Marchetti F La razionalità della prescrizione nell’uso degli antibiotici. Medico e Bambino 2016;35(9):551-553
16. Marchetti, F. Perché abbiamo paura di prescrivere bene gli antibiotici? Medico e Bambino 2019;38(4):211-2.
17. Manzotti R, Montagna G, Pinotti M, Gradellini F, Ferretti A. Prescrivere bene gli antibiotici. Medico e Bambino 2019;38(7):423.